We are a high-tech enterprise driven by innovation, integrating the research and development, production, sales, and full cycle service of pathological diagnosis products. Comprehensively covering all technical fields such as cell pathology, tissue pathology, molecular diagnosis, digital pathology, and AI assisted diagnosis, we provide innovative products and services that run through the entire diagnostic process for medical institutions.

The company is named after Rudolf Weirshaw, the father of modern pathology. This 19th-century scientific giant founded cell pathology and proposed the groundbreaking theory that 'all diseases stem from cellular pathology'. We continue its spirit of exploration and embed the academic belief of "micro insight into the essence of life" into our corporate DNA, striving to become a leader in independent innovation of pathological diagnosis in China. In the next five to ten years, we will gradually become a leading large-scale comprehensive supplier of closed-loop solutions covering the entire pathology diagnosis chain in China through a three-dimensional layout of pathology equipment, diagnostic reagents, and intelligent platforms.